Literature DB >> 17537081

Depressive symptoms and rates of bone loss at the hip in older women.

Susan J Diem1, Terri L Blackwell, Katie L Stone, Kristine Yaffe, Jane A Cauley, Mary A Whooley, Kristine E Ensrud.   

Abstract

OBJECTIVES: To ascertain whether depressive symptoms are associated with increased rates of bone loss at the hip.
DESIGN: Population-based prospective cohort study.
SETTING: Four clinical centers in the United States. PARTICIPANTS: Four thousand one hundred seventy-seven community-dwelling women, aged 69 and older, enrolled in the Study of Osteoporotic Fractures. MEASUREMENTS: Depressive symptoms were assessed using the Geriatric Depression Scale (GDS). Subjects were categorized as depressed if their GDS score was 6 or greater at the fourth examination. Bone mineral density (BMD) at the hip was measured using dual-energy x-ray absorptiometry at the fourth and sixth examinations (average 4.4 years between examinations). Use of antidepressant medications was assessed by interview and verified from medication containers at the fourth and sixth examinations of the Study of Osteoporotic Fractures. A computerized dictionary was used to categorize type of medication.
RESULTS: In age-adjusted models, mean total hip BMD decreased 0.69%/year in 3,977 women with a GDS score of less than 6, compared with 0.96%/year in 200 women with a GDS score of 6 or greater (P<.01). Results were not substantially altered when adjusted for potential confounders and when users of antidepressants were excluded from the analysis.
CONCLUSION: Depression, as defined by a GDS score of 6 or greater, was associated with an increased rate of bone loss at the hip in this cohort of older women. Clinicians should be aware of a possible increased rate of bone loss in older, depressed women.

Entities:  

Mesh:

Year:  2007        PMID: 17537081     DOI: 10.1111/j.1532-5415.2007.01194.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  27 in total

Review 1.  Depression and osteoporosis: a research synthesis with meta-analysis.

Authors:  G Cizza; S Primma; M Coyle; L Gourgiotis; G Csako
Journal:  Horm Metab Res       Date:  2010-05-07       Impact factor: 2.936

2.  Bone density and brain atrophy in early Alzheimer's disease.

Authors:  Natalia Loskutova; Robyn A Honea; Eric D Vidoni; William M Brooks; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Predicting the trajectories of depressive symptoms among southern community-dwelling older adults: the role of religiosity.

Authors:  Fei Sun; Nan S Park; Lucinda L Roff; David L Klemmack; Michael Parker; Harold G Koenig; Patricia Sawyer; Richard M Allman
Journal:  Aging Ment Health       Date:  2011-10-28       Impact factor: 3.658

4.  Rates of bone loss among women initiating antidepressant medication use in midlife.

Authors:  Susan J Diem; Kristine Ruppert; Jane A Cauley; YinJuan Lian; Joyce T Bromberger; Joel S Finkelstein; Gail A Greendale; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2013-09-03       Impact factor: 5.958

Review 5.  Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?

Authors:  Elizabeth M Haney; Stuart J Warden; M Michael Bliziotes
Journal:  Bone       Date:  2009-08-05       Impact factor: 4.398

6.  Use of antidepressant medications and risk of fracture in older women.

Authors:  Susan J Diem; Terri L Blackwell; Katie L Stone; Jane A Cauley; Teresa A Hillier; Elizabeth M Haney; Kristine E Ensrud
Journal:  Calcif Tissue Int       Date:  2011-04-01       Impact factor: 4.333

7.  Depressive symptoms, bone loss, and fractures in postmenopausal women.

Authors:  Leslie Spangler; Delia Scholes; Robert L Brunner; John Robbins; Susan D Reed; Katherine M Newton; Jennifer L Melville; Andrea Z Lacroix
Journal:  J Gen Intern Med       Date:  2008-02-20       Impact factor: 5.128

Review 8.  Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?

Authors:  Stuart J Warden; Robyn K Fuchs
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 9.  Depression, antidepressants, and bone health in older adults: a systematic review.

Authors:  Marie Anne Gebara; Marcie L O Shea; Kim L Lipsey; Steven L Teitelbaum; Roberto Civitelli; Daniel J Müller; Charles F Reynolds; Benoit H Mulsant; Eric J Lenze
Journal:  J Am Geriatr Soc       Date:  2014-07-15       Impact factor: 5.562

10.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.